Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
7.84
-0.07 (-0.88%)
At close: Sep 11, 2026, 4:00 PM EDT
7.81
-0.03 (-0.38%)
After-hours: Sep 11, 2026, 7:32 PM EDT
Evolus Market Cap
Evolus has a market cap or net worth of $517.84 million as of September 11, 2026. Its market cap has increased by 8.93% in one year.
Market Cap
517.84M
Enterprise Value
637.47M
1-Year Change
8.93%
Ranking
Category
Stock Price
$7.84
ChartMarket Cap Chart
Since February 8, 2018, Evolus's market cap has increased from $271.30M to $517.84M, an increase of 90.87%. That is a compound annual growth rate of 7.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 517.80M | 20.11% |
| Dec 31, 2025 | 431.10M | -38.34% |
| Dec 31, 2024 | 699.10M | 16.17% |
| Dec 29, 2023 | 601.80M | 42.47% |
| Dec 30, 2022 | 422.40M | 16.75% |
| Dec 31, 2021 | 361.80M | 219.05% |
| Dec 31, 2020 | 113.40M | -66.03% |
| Dec 31, 2019 | 333.80M | 2.83% |
| Dec 31, 2018 | 324.60M | 19.65% |
| Feb 8, 2018 | 271.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 747.34M |
| Collegium Pharmaceutical | 740.64M |
| Ironwood Pharmaceuticals | 674.18M |
| Evotec SE | 612.30M |
| Aquestive Therapeutics | 599.95M |
| Tilray Brands | 550.71M |
| Kamada | 464.97M |
| Canopy Growth | 390.33M |